Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3QX9

Crystal structure of MID domain from hAGO2 in complex with ATP

Summary for 3QX9
Entry DOI10.2210/pdb3qx9/pdb
Related3LUC 3QX8
DescriptorProtein argonaute-2, ADENOSINE-5'-TRIPHOSPHATE (3 entities in total)
Functional Keywordsrossmann-like fold, rna binding protein
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm, P-body: Q9UKV8
Total number of polymer chains3
Total formula weight47499.41
Authors
Frank, F.,Fabian, M.R.,Stepinski, J.,Jemielity, J.,Darzynkiewicz, E.,Sonenberg, N.,Nagar, B. (deposition date: 2011-03-01, release date: 2011-04-20, Last modification date: 2024-02-21)
Primary citationFrank, F.,Fabian, M.R.,Stepinski, J.,Jemielity, J.,Darzynkiewicz, E.,Sonenberg, N.,Nagar, B.
Structural analysis of 5'-mRNA-cap interactions with the human AGO2 MID domain.
Embo Rep., 12:415-420, 2011
Cited by
PubMed Abstract: In RNA silencing, microRNA (miRNA)-mediated translational repression occurs through mechanisms that do not invoke messenger-RNA (mRNA) target cleavage by Argonaute proteins. The nature of these mechanisms is unclear, but several recent studies have proposed that a direct interaction between the mRNA-cap and the middle (MID) domain of Argonautes is involved. Here, we present crystallographic and NMR data demonstrating that cap analogues do not bind significantly to the isolated MID domain of human Argonaute 2 (hAGO2) and are found in the miRNA 5'-nucleotide binding site in an implausible binding mode. Additionally, in vitro pull-down experiments with full-length hAGO2 indicate that the interaction with cap analogues is nonspecific.
PubMed: 21475248
DOI: 10.1038/embor.2011.48
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon